-
$2,000 Read More Nocturia – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Nocturia - Pipeline Review, H1 2016’, provides an overview of the Nocturia pipeline landscape. The report provides comprehensive information on the therapeutics under development for Nocturia, complete with analysis by stage of development, drug target, mechanism of acti... -
$2,000 Read More Renal Insufficiency – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Renal Insufficiency - Pipeline Review, H1 2016’, provides an overview of the Renal Insufficiency pipeline landscape. The report provides comprehensive information on the therapeutics under development for Renal Insufficiency, complete with analysis by stage of developmen... -
$2,000 Read More Prader-Willi Syndrome (PWS) – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Prader-Willi Syndrome (PWS) - Pipeline Review, H1 2016’, provides an overview of the Prader-Willi Syndrome (PWS) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Prader-Willi Syndrome (PWS), complete with analysi... -
$2,000 Read More Hepatic Encephalopathy – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Hepatic Encephalopathy - Pipeline Review, H1 2016’, provides an overview of the Hepatic Encephalopathy pipeline landscape. The report provides comprehensive information on the therapeutics under development for Hepatic Encephalopathy, complete with analysis by stage of d... -
$2,000 Read More Fecal Incontinence – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Fecal Incontinence - Pipeline Review, H1 2016’, provides an overview of the Fecal Incontinence pipeline landscape. The report provides comprehensive information on the therapeutics under development for Fecal Incontinence, complete with analysis by stage of development, ... -
$2,000 Read More Functional (Non Ulcer) Dyspepsia – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Functional (Non Ulcer) Dyspepsia - Pipeline Review, H1 2016’, provides an overview of the Functional (Non Ulcer) Dyspepsia pipeline landscape. The report provides comprehensive information on the therapeutics under development for Functional (Non Ulcer) Dyspepsia, comple... -
$2,500 Read More Primary Sclerosing Cholangitis – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Primary Sclerosing Cholangitis - Pipeline Review, H1 2016’, provides an overview of the Primary Sclerosing Cholangitis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Primary Sclerosing Cholangitis, complete wit... -
$2,000 Read More Otitis Media – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Otitis Media - Pipeline Review, H1 2016’, provides an overview of the Otitis Media pipeline landscape. The report provides comprehensive information on the therapeutics under development for Otitis Media, complete with analysis by stage of development, drug target, mecha... -
$2,000 Read More Nasopharyngitis (Common Cold) – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Nasopharyngitis (Common Cold) - Pipeline Review, H1 2016’, provides an overview of the Nasopharyngitis (Common Cold) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Nasopharyngitis (Common Cold), complete with a... -
$2,000 Read More Acute Sensorineural Hearing Loss – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Acute Sensorineural Hearing Loss - Pipeline Review, H1 2016’, provides an overview of the Acute Sensorineural Hearing Loss pipeline landscape. The report provides comprehensive information on the therapeutics under development for Acute Sensorineural Hearing Loss, comple...
Sorry, there is no ad related to this category!
-
$6,995 Read More Frontier Pharma: Obesity – Identifying and Commercializing First-in-Class ...
Obesity is a major growing health concern around the world. In most markets, a person […]
-
$2,000 Read More Acute Heart Failure – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Acute Heart Failure – Pipeline Review, H1 2016’, provides an overview of […]
-
$2,000 Read More Cognitive Impairment Associated With Schizophrenia (CIAS) – Pipeline Revie...
Global Markets Direct’s, ‘Cognitive Impairment Associated With Schizophrenia (CIAS) – Pipeline Review, H1 2016’, provides […]
-
$2,500 Read More Blepharitis Global Clinical Trials Review, H1, 2016
This report provides top line data relating to the clinical trials on Blepharitis. Report includes […]
-
$1,500 Read More SK Biopharmaceuticals Co., Ltd. – Product Pipeline Review – 2015
Global Markets Direct’s, ‘SK Biopharmaceuticals Co., Ltd. – Product Pipeline Review – 2015’, provides an […]
-
$2,500 Read More Primary Sclerosing Cholangitis – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Primary Sclerosing Cholangitis – Pipeline Review, H1 2016’, provides an overview of […]
-
$4,995 Read More Alzheimer’s Therapeutics in Asia-Pacific Markets to 2021 – Growth Driven...
Alzheimer Disease (AD) is an irreversible, progressive neurodegenerative disease, characterized by cognitive impairment, memory loss […]
-
$2,500 Read More Bronchiectasis Global Clinical Trials Review, H1, 2016
This report provides top line data relating to the clinical trials on Bronchiectasis. Report includes […]
-
$4,995 Read More Alzheimer’s Disease Therapeutics in Major Developed Markets to 2021 – Ag...
Alzheimer’s Disease (AD) is an irreversible, progressive neurodegenerative disease, characterized by cognitive impairment, memory loss […]
-
$1,500 Read More Biotie Therapies Corp. – Product Pipeline Review – 2015
Global Markets Direct’s, ‘Biotie Therapies Corp. – Product Pipeline Review – 2015’, provides an overview […]
